Back
Syndax Pharmaceuticals Vs. Bowman Consulting Group Industry Stock Comparison
Buy
63
SNDX
Syndax Pharmaceuticals
Last Price:
21.08
Seasonality Move:
6.88%
Sell
38
BWMN
Bowman Consulting Group
Last Price:
32.87
Seasonality Move:
-5.05%
Buy
63
Syndax Pharmaceuticals (SNDX)
is a Buy
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $21.06. The Score for SNDX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- SNDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Bowman Consulting Group (BWMN)
is a Sell
Is Bowman Consulting Group a Buy, Sell or Hold?
- The current Bowman Consulting Group [BWMN] share price is $32.95. The Score for BWMN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BWMN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $21.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BWMN Stock Price Chart
What is Bowman Consulting Group's stock price today?
-
The Bowman Consulting Group share price today is $32.95
The current trend is relatively stagnant and BWMN is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 43.11 | Sell |
Chaikin Money Flow: | 366056 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.96 - 23.1) | Sell |
Bollinger Bands (100): | (19.87 - 23.39) | Sell |
BWMN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.97 | Sell |
Relative Strength Index (14 RSI): | 50.62 | Buy |
Chaikin Money Flow: | 64449 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.15 - 35.93) | Sell |
Bollinger Bands (100): | (30.95 - 36.57) | Sell |
SNDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.8 | Buy |
20-day SMA: | 21.88 | Sell |
50-day SMA: | 22.64 | Sell |
200-day SMA: | 19.07 | Buy |
8-day EMA: | 21 | Buy |
20-day EMA: | 21.58 | Sell |
50-day EMA: | 21.92 | Sell |
200-day EMA: | 20.47 | Buy |
BWMN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.17 | Buy |
20-day SMA: | 31.78 | Buy |
50-day SMA: | 34.47 | Sell |
200-day SMA: | 31.57 | Buy |
8-day EMA: | 31.73 | Buy |
20-day EMA: | 32.39 | Buy |
50-day EMA: | 33.47 | Sell |
200-day EMA: | 31.57 | Buy |
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and an increase next year of $1.08 per share.
Bowman Consulting Group Earnings Growth & BWMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.61 per share, and an increase next year of $0.38 per share.
Syndax Pharmaceuticals Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bowman Consulting Group Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |